OPTIMA Fémina Ménopause
Food supplement declared in France, declaration No 2019-1-730
OPTIMA Fémina Ménopause (Laboratoires Vitarmonyl) is a food supplement declared in France. Status: retiré du marché le 30 June 2025. 1 point in its composition requires a check (prohibited substance, dose or novel food). 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- Laboratoires Vitarmonyl
- Food business operator placing the product on the market
- Laboratoires VITARMONYL
- Status
- Retiré du marché le 30 June 2025
- Form
- Capsule
- Daily dose
- 1 capsule JOUR + 1 capsule NUIT
- Directions for use
- à avaler
- Intended populations
- Femme
- Not recommended for (according to the manufacturer)
- Antécédent de cancer du sein
- Objectives stated by the manufacturer (these are not authorised claims)
- Antioxydant, Peau, Ménopause, Immunité
Declaration 161388, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- À vérifier
Borago spp. (zie ook lijst 3/voir aussi liste 3): dangerous plant prohibited in food in Belgium (list 1). The entire genus Borago is listed. L'utilisation de petites quantités de fleurs de Borago officinalis L. dans les préparations culinaires est autorisée. List 3 also covers Borago officinalis L., parts: fleur, graine. Le complément alimentaire doit être conforme aux dispositions de la section 2.4 (alcaloïdes pyrrolizidiniques ) de l'annexe du règlement (UE) 2023/915 de la Commission du 25 avril 2023 concernant les teneurs maximales pour certains contaminants dans les denrées alimentaires et abrogeant le règlement (CE) no 1881/2006. Le dossier de notification doit démontrer cette conformité par analyse. Check the plant part used, the preparation, the conditions and the product notification.
Source: Belgium, Royal Decree of 31 August 2021, plant lists (annex replaced on 30 January 2024), arrêté royal du 31 août 2021, annexe remplacée le 30 janvier 2024, liste 1, page PDF 66 ; liste 3, pages PDF 124.
- Conditions légales
Borago officinalis L.: Les préparations de cette plante sont autorisées s'il peut être démontré qu'elles ne dépassent pas 1 ppb d'alcaloïdes pyrrolizidiniques.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Information
Retiré du marché le 30 June 2025, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Citrus sinensis (L.) Osbeck | Fruit | Extrait sec aqueux | 170 mg |
| Lithothamnion calcareum (Pallas) Areschoug | Thalle | Poudre (de plantes séchées ou broyées) | 150 mg |
| Borago officinalis L. | Graine (huile) | Pression à froid | 135 mg |
| Humulus lupulus L. | Cône | Extrait sec hydroalcoolique | 80 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Huile de poisson | not declared |
| Huile de foie de morue | not declared |
| Phospholipides | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Béta-carotène | Bêta-carotène | pas de limite (données insuffisantes) | aucune dose fixée |
| Gluconate ferreux | Fer | 40 mg (niveau de sécurité) | 14 mg |
| Acide ptéroylmonoglutamique | Folates (vitamine B9) | 1,000 µg | 200 µg |
| Levure enrichie en sélénium | Sélénium | 255 µg | 50 µg |
| Chlorhydrate de thiamine | Vitamine B1 (thiamine) | pas de limite (données insuffisantes) | dose annulée par le Conseil d'État en 2011 |
| Chlorhydrate de pyridoxine | Vitamine B6 | 12 mg | 2 mg |
| D-alpha-tocophérol | Vitamine E | 300 mg | 30 mg |
| Gluconate de zinc | Zinc | 25 mg | 15 mg |
Additives
E422, E172, E322, E471, E150d
Other ingredients
Gélatine de poisson, huile de soja, Cire d'abeille, huile de tournesol
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Il est recommandé de ne pas consommer en même temps d'autres produits contenant de la vitamine A ou du sélénium.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Borago officinalis L.
Read the warning, when it applies and the studies cited
- Humulus lupulus L.
Read the warning, when it applies and the studies cited
HOPS - HUMULUS LUPULUS
Route of administration: Oral
Cautions and warnings
Condition of application: Sleep aid.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if sleeplessness persists continuously for more than 4 weeks (chronic insomnia) (Berardi et al. 2002; Dipiro et al. 2002).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Other uses.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Barnes et al. 2007; Mills and Bone 2005; McGuffin et al. 1997).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
When using this product avoid taking with alcohol or products that cause drowsiness (Brinker 2010).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
When using this product exercise caution if you drive or use machinery as this product may cause drowsiness (EMA 2014).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
- Huile de poisson
Read the warning, when it applies and the studies cited
FISH OIL
Route of administration: Oral
Cautions and warnings
Condition of application: Pain of rheumatoid arthritis.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
Condition of application: Healthy mood balance.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression.
- Huile de foie de morue
Read the warning, when it applies and the studies cited
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : Laboratoires Vitarmonyl
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.